Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Imirestat (HOE 843) is an aldose reductase inhibitor that can be used in diabetes research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 155.00 | |
5 mg | In stock | $ 328.00 | |
10 mg | In stock | $ 563.00 | |
25 mg | In stock | $ 890.00 | |
50 mg | In stock | $ 1,230.00 | |
100 mg | In stock | $ 1,670.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 495.00 |
Description | Imirestat (HOE 843) is an aldose reductase inhibitor that can be used in diabetes research. |
In vivo | Administration of 1 mg/kg Imirestat increased nerve conduction velocity, however, had no effect on resistance to hypoxic conduction block or deficits in insulin-stimulated Uban-sensitive ATPase activity[1]. |
Synonyms | Alcon 1576, AL 1576, HOE 843 |
Molecular Weight | 286.23 |
Formula | C15H8F2N2O2 |
CAS No. | 89391-50-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (349.37 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Imirestat 89391-50-4 Endocrinology/Hormones Metabolism Reductase Alcon 1576 HOE843 AL-1576 inhibit AL 1576 AL1576 HOE 843 Aldose Reductase HOE-843 Alcon-1576 Inhibitor Alcon1576 inhibitor